Your browser doesn't support javascript.
loading
Existing highly accumulating lysosomotropic drugs with potential for repurposing to target COVID-19.
Norinder, Ulf; Tuck, Astrud; Norgren, Kalle; Munic Kos, Vesna.
Afiliación
  • Norinder U; Department of Computer and Systems Sciences, Stockholm University, Box 7003, SE-164 07 Kista, Sweden; MTM Research Centre, School of Science and Technology, Örebro University, SE-701 82 Örebro, Sweden.
  • Tuck A; Department of Physiology and Pharmacology, Karolinska Institutet, SE-171 77 Stockholm, Sweden.
  • Norgren K; Department of Physiology and Pharmacology, Karolinska Institutet, SE-171 77 Stockholm, Sweden.
  • Munic Kos V; Department of Physiology and Pharmacology, Karolinska Institutet, SE-171 77 Stockholm, Sweden. Electronic address: vesna.munic.kos@ki.se.
Biomed Pharmacother ; 130: 110582, 2020 Oct.
Article en En | MEDLINE | ID: mdl-32763818

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Antivirales / Neumonía Viral / Infecciones por Coronavirus / Reposicionamiento de Medicamentos / Pandemias / Betacoronavirus / Lisosomas Tipo de estudio: Etiology_studies / Prognostic_studies Idioma: En Revista: Biomed Pharmacother Año: 2020 Tipo del documento: Article País de afiliación: Suecia

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Antivirales / Neumonía Viral / Infecciones por Coronavirus / Reposicionamiento de Medicamentos / Pandemias / Betacoronavirus / Lisosomas Tipo de estudio: Etiology_studies / Prognostic_studies Idioma: En Revista: Biomed Pharmacother Año: 2020 Tipo del documento: Article País de afiliación: Suecia